Bafna Pharmaceuticals Limited
Share Price Target & Analysis
NSE:BAFNAPH
VWAP
Open
Close
High
Low
52 Week High
-6.15 (-2%)
BAFNAPH
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Diamond
Valuation
#Analysis
NSE: BAFNAPH Share Price Financial Analysis & Valuation
Bafna Pharmaceuticals Limited (BAFNAPH) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of SME Stocks company with Market Capitalization of Rs 321.7 (in Cr). Total number of free float shares are 0 (in Lacs).
Bafna Pharmaceuticals Limited is listed on NSE with Exchange ID - INE878I01022 and trading code is NSE:BAFNAPH with short name Bafna Pharma.
In the past 1 year, Bafna Pharmaceuticals Limited has declared an equity dividend of Rs 0 per share. At the current share price of BAFNAPH at Rs 301.85, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:BAFNAPH, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine BAFNAPH underlying value and future prospects. All of this data is available in BAFNAPH financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:BAFNAPH, it is clearly understood that BAFNAPH is Economical performer in terms of earnings and profit margins with an EPS of 3.29. NSE:BAFNAPH book value per share as of today is 40.68. The current price to book ratio for BAFNAPH as of Sep 09, 2026 is 7.42.
Valuation of the Stock: The current valuation of BAFNAPH stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of BAFNAPH whether to BUY this stock at current valuation. The delivery percentage of BAFNAPH is 0% is very crucial parameter which shows that 0% investors are anticipating that the price of BAFNAPH share should go up with VWAP at 304.68.
Now, the main question is whether to BUY or SELL, NSE:BAFNAPH at current valuation.
As per latest Analysis No. #1172:-
⇑ STRONG BUY BAFNAPH if All Greens
⇗ BUY BAFNAPH (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD BAFNAPH (With Stop Loss) if only 1 Green
⇘ SELL BAFNAPH if NO Green Indicator
NSE: BAFNAPH Share Price Today (Sep 09, 2026)
(Bafna Pharmaceuticals Limited Daily Analysis on the basis of BAFNAPH Intraday Graph & Trend)
Bafna Pharmaceuticals Limited share price moved Down by -2% from its previous close of Rs 308. BAFNAPH stock last traded price is 301.85. BAFNAPH share price trend is Down with a total of 4454 stocks traded till now. It has touched an intraday high of Rs 307.5 and an intraday low of Rs 301.85. The BAFNAPH trading at 301.85, Down by Rs. -6.15, or -2 percent which suggests that most of the Traders are anticipating that the price of BAFNAPH share should go Down.
NSE: BAFNAPH Share Price Tomorrow Prediction
(Bafna Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of BAFNAPH)
Bafna Pharmaceuticals Limited share price moved Down by -2%. BAFNAPH share price short term trend is Down. It suggests that BAFNAPH Share Price for Tomorrow remains the same with VWAP at 304.68 will be treated as stop loss for intraday traders. Bafna Pharmaceuticals Limited Long term investors can follow the BAFNAPH long term trend as mentiond in future forecast table.
NSE Code |
NSE: BAFNAPH |
BAFNAPH Share Price Today |
301.85 |
BAFNAPH Share Price Target Prediction for 2026 ^ |
199.2 - 320.1 |
BAFNAPH Share Price Target Prediction for 2027*^ |
320.1 - 341 |
BAFNAPH Share Price Target Prediction for 2028*^ |
341 - 364.9 |
BAFNAPH Share Price Target Prediction for 2029*^ |
383 |
BAFNAPH Share Price Target Prediction for 2030*^ |
394 |
BAFNAPH Share Price Target Prediction for 2035*^ |
430 |
| BAFNAPH Current Book Value |
40.5 |
*Bafna Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^BAFNAPH share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
BAFNAPH Technical Analysis
Candlestick Pattern: @312.6| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 293.21 | BUY | 294.38 | BUY |
| MA_12 | 266.79 | BUY | 277.23 | BUY |
| MA_20 | 270.06 | BUY | 269.82 | BUY |
| MA_32 | 259.89 | BUY | 256.52 | BUY |
| MA_50 | 242.85 | BUY | 242.05 | BUY |
| MA_100 | 200.19 | BUY | 214.78 | BUY |
| MA_200 | 162.55 | BUY | 175.68 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 310.15 | OverBought |
| MACD | 3.88 | BUY |
| ADX | 32.58 | Strong Trend |
| DMI (+/-) | 60.9 / 25.2 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 75.82 | Overbought |
| STOCHASTIC_K (Fast) | 92.31 | Overbought |
| STOCHASTIC_D (Slow) | 97.94 | Overbought |
| CCI | 166.26 | BUY |
| PSAR | 248.81 | BUY |
| TRUE RANGE | 17.5 | Neutral |
| ATR | 9.32 | BUY |
| WILLIAMS R | -6.9 | Overbought |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 100 | Overbought |
| STOCHASTIC RSI D | 100 | Overbought |
| MOMENTUM | 44.4 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 211.29% |
| 3 Months | 125.72% |
| 1 Month | 16.55% |
| 1 Week | 16.97% |
| Action | Overall (%) |
|---|---|
| BUY | 93% |
| NEUTRAL / HOLD | 7% |
| SELL | 0% |
Most popular Questions & Answers about BAFNAPH (/ FAQ BAFNAPH)
Bafna Pharmaceuticals Limited stock last traded price is 301.85. BAFNAPH share price moved Down by -2% from its previous close of Rs 308.
Bafna Pharmaceuticals Limited share price trend is Down with a total of 4454 stocks traded till now. It has touched an intraday high of Rs 321.685 and an intraday low of Rs 301.85. The BAFNAPH trading at 301.85, Down by Rs. -6.15, or -2 percent which suggests that most of the Traders are anticipating that the price of BAFNAPH share should go Down and the Stop Loss will be around 304.68.
The market cap of Bafna Pharmaceuticals Limited is ₹321.7 (in Cr) as of Sep 08, 2026.
The current price to earning ratio for Bafna Pharmaceuticals Limited as of Sep 08, 2026 is 52.86.
The current price to book ratio for Bafna Pharmaceuticals Limited as of Sep 08, 2026 is 7.42.
The highest price of Bafna Pharmaceuticals Limited stock is ₹318.5 in the last 52-week.
The lowest price of Bafna Pharmaceuticals Limited stock is ₹94.77 in the last 52-week.
Bafna Pharmaceuticals Limited share trading at ₹301.85, Down by Rs. -6.15, or -2 percent which suggests that most of the traders are anticipating that the price of BAFNAPH share should go Down.
In 2026, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹199.2 on downside and ₹320.1 on upside. Bafna Pharmaceuticals Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹320.1 on downside and ₹341 on upside. Bafna Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹341 on downside and ₹364.9 on upside. Bafna Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹394 Bafna Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of BAFNAPH.
The price of Bafna Pharmaceuticals Limited (BAFNAPH) shares moved by -2%. The short-term trend for BAFNAPH share price is Down. It implies that the share price of BAFNAPH will stay the same tomorrow and that intraday traders should treat VWAP at 304.68 as a stop loss. Investors with a long-term outlook can track BAFNAPH long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of BAFNAPH stock is 39.4. Compared to the current market price of 301.85 INR, the BAFNAPH stock is Overvalued by 86.9%.
As per the fundamental analysis of Bafna Pharmaceuticals Limited (BAFNAPH), it is of Economical quality in terms of earnings and profit margins with an EPS of 3.29. Bafna Pharmaceuticals Limited book value per share as of today is 40.68. The current price to book ratio for BAFNAPH as of Sep 09, 2026 is 7.42.
NSE:BAFNAPH News & Other Useful Information about BAFNAPH Share Price
Peer Comparison of NSE: BAFNAPH
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1885.90 | 16.35 | 97.89 |
| DIVISLAB | 9575.00 | 115.55 | 663.06 |
| MEDICAMEQ | 285.75 | 12.15 | 208.08 |
| CIPLA | 1384.00 | 51.67 | 434.03 |
| DRREDDY | 1151.00 | 53.19 | 380.63 |
| TORNTPHARM | 4960.00 | 87.32 | 235.7 |
| BIOCON | 392.30 | 1.27 | 166.51 |
| LUPIN | 2104.70 | 154.86 | 718.37 |
| ALKEM | 5181.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1692.00 | 46.49 | 403.84 |
| ABBOTINDIA | 25555.00 | 766.11 | 2448.41 |
| GLAXO | 2928.20 | 63.65 | 147.25 |
| IPCALAB | 1967.20 | 56.72 | 329.23 |
| LAURUSLABS | 1946.90 | 20.74 | 102.57 |
| LALPATHLAB | 1912.50 | 39.68 | 157.23 |
| PFIZER | 4310.70 | 170.54 | 963.41 |
| AJANTPHARM | 3579.30 | 89.3 | 363.23 |
| SANOFI | 3114.90 | 158.05 | 332.96 |
| NATCOPHARM | 825.75 | 82.14 | 481.67 |
| APLLTD | 808.50 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2474.50 | 1.24 | 881.78 |
| AAREYDRUGS | 98.03 | 2.39 | 53.38 |
| JUBLPHARMA | 997.75 | 4.35 | 145.63 |
| SPARC | 203.27 | 48.14 | 40.45 |
| GRANULES | 895.35 | 23.25 | 180.42 |
| ASTRAZEN | 6875.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2770.10 | 55.52 | 285.6 |
| FDC | 345.95 | 21.19 | 161.21 |
| HIKAL | 247.00 | 9.34 | 96.63 |